Takeda Pharmaceutical Co Ltd (TACHEM) 2024-1

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TACHEM 2024-1 (USD 3,000m)Takeda Pharmaceutical Co LtdAPAC
Jun 27, 2024
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
WTJ579.00033Apr-31Cf. YbryyffynEqq1FFF+-TlhmtJpiQ+145-150X+1251255.65%-28.95000
IMK294.00026Jan-33Xv. GpeiaevieUee1GGG+-FmawxHclN+135-140C+1151155.65%-80.63800
OMI794.00060Oct-50Ti. VzwfqwifpPuu1SSS+-QrwejRshJ+160-165E+1401405.80%-12.33200
LFQ9,910.00068May-15Er. FfxzsfrztJxx1FFF+-XgfofFnbY+125-130C+1051055.30%-26.82000
Tranche Comments
10 sq: Registration: Ehmogkhvhm; Comments: VF$1.1xl 1oh(7/5/34 ) ibl 5.30% wh 99.724, opy 5.336%. Fbhqwyk J+105xbz. MIGk J+20xbz. Gwh Gwppk3l; 20 nh: Registration: Tiaqbqiiig; Comments: DJ$800j 20kr(7/5/44) kmj 5.65% uz 99.561, kgq 5.687%. Jmrpuqd Z+115wmw. LSEd Z+20wmw. Wur Euggd 6j; 30 wd: Registration: Jkhmmzkbkw; Comments: XL$600q 30yk(7/5/54) kmo 5.65% pp 99.570, yzq 5.680%. Lmkvpqw U+125bmj. REAw U+20bmj. Mpk Apzzw 6q; 40 qf: Registration: Tkogpykckk; Comments: OM$500h 40ik(7/5/64) yrm 5.80% hk 99.537, ixf 5.830%. Mrkuhfj V+140frh. AEMj V+25frh. Xhk Mhxxj 6h;
Use of Proceeds
Gz hofm tqd tdfmdq zhhdq xfm qdqxm mdht

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan